Tobias J. Lange
- Switch of patients with pulmonary arterial hypertension after withdrawal of the endothelin receptor antagonist sitaxentanBy David Pittrow, Ardeschir Ghofrani, Stephan Rosenkranz, Ekkehard Grünig, Dörte Huscher, Henning Tiede, Marion Delcroix, Gerd Stähler, Michael Halank, Matthias Held, Christian Grohé, Tobias J. Lange, Jürgen Behr, Hans Klose, Heinrike Wilkens, Rudolph Speich, Christian M. Kähler, Arthur Filusch, Martin Germann, Ralf Ewert, Hans-Jürgen Seyfarth, Karen M. Olsson, Christian F. Opitz, Sean P. Gaine, C. Dario Vizza, Anton Vonk-Noordegraaf, Harald Kaemmerer, J. Simon R. Gibbs, Oliver Distler, Christian Schweiger and Marius M. HoeperDavid Pittrow1Institute for Clinical Pharmacology, Technical University, Medical Faculty, Dresden, GermanyArdeschir Ghofrani2Department of Pneumology, Medical Clinic II, University of Giessen Lung Center, Giessen, GermanyStephan Rosenkranz3Clinic III for Internal Medicine (Cardiology), University Hospital, Cologne, GermanyEkkehard Grünig4Centre for Pulmonary Hypertension, Thoraxclinic, Heidelberg, GermanyDörte Huscher5Epidemiology Unit, German Rheumatism Research Centre, and Charité, Berlin, GermanyHenning Tiede2Department of Pneumology, Medical Clinic II, University of Giessen Lung Center, Giessen, GermanyMarion Delcroix7Dept. of Pneumology, University Hospitals, Leuven, BelgiumGerd Stähler8Medical Clinic I, Clinic Loewenstein, Loewenstein, GermanyMichael Halank9Internal Medicine I, University Hospital, Technical University, Dresden, GermanyMatthias Held10Dept. of Internal Medicine, Respiratory Medicine and Cardiology, Mission Medical Hospital, Würzburg, GermanyChristian Grohé11Dept. of Respiratory Medicine, ELK Thorax Center, Berlin, GermanyTobias J. Lange12Dept. of Internal Medicine II, Division of Pneumology, University Medical Center, Regensburg, GermanyJürgen Behr13Department of Internal Medicine V Comprehensive Pneumology Center Munich (CPC-M), University of Munich, Munich, GermanyHans Klose14Dept. of Respiratory Medicine, University Medical Center Hamburg-Eppendorf, Center of Oncology, Hamburg, GermanyHeinrike Wilkens15Dept. of Respiratory Medicine, University Hospital Saarland, Homburg, GermanyRudolph Speich16Clinic for Internal Medicine, University Hospital, Zurich, SwitzerlandChristian M. Kähler17Pneumology, University Hospital, Innsbruck, AustriaArthur Filusch18Dept. of Cardiology and Pneumology, University Hospital, Heidelberg, GermanyMartin Germann19Dept.of Pneumology, University Medical Centre, Freiburg, GermanyRalf Ewert20Clinic of Internal Medicine, Dept. of Respiratory Medicine, University of Greifswald, Greifswald, GermanyHans-Jürgen Seyfarth21Dept.of Respiratory Medicine, University Hospital, Leipzig, GermanyKaren M. Olsson6Dept of Respiratory Medicine and German Center of Lung Research, Hannover Medical School, Hannover, GermanyChristian F. Opitz22Dept. of Cardiology, DRK Kliniken Köpenick, Berlin, GermanySean P. Gaine23Dept. of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, IrelandC. Dario Vizza24Dept. of Cardiovascular and Respiratory Diseases, Sapienza University, Rome, ItalyAnton Vonk-Noordegraaf25Dept. of Pulmonary Diseases, VU University Medical Center, Amsterdam, NetherlandsHarald Kaemmerer26Dept. of Pediatric Cardiology and Congenital Cardiac Defects, German Heart Centre Munich, Munich, GermanyJ. Simon R. Gibbs27Dept. of Cardiology, National Heart & Lung Institute, Imperial College, London, United KingdomOliver Distler29Dept. of Rheumatology, University Hospital, Zurich, SwitzerlandChristian Schweiger28Inst. for Education in Pharmaceutical Medicine, University, Duisburg-Essen, GermanyMarius M. Hoeper6Dept of Respiratory Medicine and German Center of Lung Research, Hannover Medical School, Hannover, Germany
- Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registryBy Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn and Gerald SimonneauMichael Halank1Medical Clinic I, Department of Pneumology, University Hospital Carl Gustav Carus, Dresden, GermanyMarc Humbert2Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, FranceMiguel-Angel Gomez Sanchez3Unidad de Insuficiencia Cardiaca, Trasplante e Hipertensión Pulmonar, CIBERES, Hospital Universitario, Madrid, SpainDavid Pittrow4Institute for Clinical Pharmacology, Medical Faculty, Technical University, Carl Gustav Carus, Dresden, GermanyMarius Hoeper5Department of Respiratory Medicine and the German Center of Lung Research, Hanover Medical School, Hanover, GermanyEkkehard Grünig6Department of Respiratory Medicine, University of Leipzig, Leipzig, GermanyH. Ardeschir Ghofrani7Department of Internal Medicine, University Hospital Giessen and Marburg, Giessen, GermanyHubert Wirtz8Department of Respiratory Medicine, University of Leipzig, Leipzig, GermanyHans Klose9Section Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanyRalf Ewert10Department of Internal Medicine B - Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, Ernst-Moritz-Arndt University, Greifwald, GermanyTobias J. Lange11Department of Internal Medicine II, Division of Pneumology, University Medical Center, Regensburg, GermanyJens Klotsche12German Rheumatism Research Centre Berlin, Leibniz Institute, Berlin, GermanyChristian Meier13Bayer Pharma AG, Global Development, Global Medical Affairs, Berlin, GermanyMonika Brunn13Bayer Pharma AG, Global Development, Global Medical Affairs, Berlin, GermanyGerald Simonneau2Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, France
- Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH)By Ekkehard Grünig, Benjamin Egenlauf, Tobias J. Lange, Ulrich Krüger, Rob Grover, Michelle Pernow, Andrew Traube, Thomas Viethen and Stephan RosenkranzEkkehard Grünig1Center for Pulmonary Hypertension, Thoraxclinic, University Hospital Heidelberg, Heidelberg, GermanyBenjamin Egenlauf1Center for Pulmonary Hypertension, Thoraxclinic, University Hospital Heidelberg, Heidelberg, GermanyTobias J. Lange2Devision of Internal Medicine II, University Hospital Regensburg, Regensburg, GermanyUlrich Krüger3Department of Cardiology, University Hospital Niederrhein, Duisburg, GermanyRob Grover4United Therapeutics Europe Limited, United Therapeutics Europe Limited, Chertsey, United KingdomMichelle Pernow4United Therapeutics Europe Limited, United Therapeutics Europe Limited, Chertsey, United KingdomAndrew Traube4United Therapeutics Europe Limited, United Therapeutics Europe Limited, Chertsey, United KingdomThomas Viethen5Dept. of Cardiology and Cologne Cardiovascular Research Center (CCRC), Heart Center at the University of Cologne, Cologne, GermanyStephan Rosenkranz5Dept. of Cardiology and Cologne Cardiovascular Research Center (CCRC), Heart Center at the University of Cologne, Cologne, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.